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DBackground: For patients with aortic regurgitation (AR), aortic valve (AV) repair represents an attractive
alternative to AV replacement (AVR), because it does not expose patients to the risk of prosthetic valve compli-
cations. Although the durability of AV repair has been documented, its prognosis has not yet been compared with
prognosis of AVR.
Methods: We performed a propensity score analysis to match patients who underwent surgical correction of
severe AR by either AVR or AV repair between 1995 and 2012. After matching, 44 pairs of patients were
compared regarding baseline characteristics; overall survival; operative survival; cardiac events, including
reoperations; recurrent AR; and New York Heart Association functional class at final follow-up.
Results:Operative mortality was similar in the AV repair and AVR groups (2% vs 5%; P¼ .56). Kaplan-Meier
survival analysis indicated a significantly better overall 9-year survival after AV repair than after AVR (87% vs
60%; P ¼ .007). Cox proportional survival analysis demonstrated that the choice of treatment was an indepen-
dent predictor of postoperative survival. Finally, AV repair resulted in a slight increase, albeit not statistically
significant, in reoperation rate (8% vs 2%; log rank P ¼ .35).
Conclusions: AV repair significantly improves postoperative outcomes in patients with AR and whenever
feasible should probably be the preferredmode of surgical correction. (J Thorac Cardiovasc Surg 2014;148:1913-20)Aortic valve (AV) replacement (AVR) is an established
treatment for patients with severe AV regurgitation
(AR).1,2 AVR improves prognosis and quality of life, but
exposes patients to a variety of prosthesis-related complica-
tions.3 Mechanical valves are associated with the risks of
thromboembolism, valve thrombosis, and anticoagulation-
related bleeding, whereas biological valve substitutes un-
dergo structural degeneration and expose patients to the
risk of reoperation.4 The risk of prosthetic valve endocardi-
tis also remains for both biological and mechanical substi-
tutes. Taken together, the cumulative risk of valve-related
complications has been estimated to be around 50% at 10
years in patients undergoing AVR for the treatment
of AR.4,5
In recent years, repair techniques for diseased AVs have
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The Journal of Thoracic and Carmaintaining the normal architecture of the AV apparatus
would be beneficial to the patient.6-9 Thanks to
innovations in operative techniques,9 an improved under-
standing of the functional anatomy of the aortic valve and
root,10 as well as increased awareness of the mechanisms
leading to AR,11 AV repair has progressively evolved
from an anecdotal approach to a plausible alternative to
AVR. Several studies have indeed demonstrated that AV
repair is feasible in a majority of patients with AR due to
aortic root diseases or cusp prolapses and results in a low
incidence of valve-related complications, including reoper-
ations.7-12 Despite these promising results, it is still
uncertain if reconstruction of the AV provides survival
advantages over AVR, as observed in mitral valve surgery.
We examined the outcome after AV repair or AVR in pa-
tients with severe AR, hypothesizing that AV repair would
improve overall survival compared with AVR. Because
comparison between these 2 operative approaches can be
obscured by differences in baseline characteristics, the tech-
nique of propensity score matching was used to reduce
selection bias and heterogeneity in the study population.METHODS
Study Population
The study population consisted of 942 consecutive patients who under-
went surgical correction of AR or for dilation of the ascending aorta
between January 1, 1995, and December 31, 2012. Exclusion criteria
(Figure 1) were missing preoperative data (n ¼ 47), AV surgery without
severe AR, primary surgery for dilation of the ascending aorta, coronarydiovascular Surgery c Volume 148, Number 5 1913
Abbreviations and Acronyms
AR ¼ aortic regurgitation
AV ¼ aortic valve
AVR ¼ aortic valve replacement
NYHA ¼ New York Heart Association
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myxoma (n ¼ 307).
Among 588 patients with severe AR, those aged<18 years (n ¼ 24);
severe acute AR due to endocarditis or aortic dissection (n¼ 81); concom-
itant severe mitral regurgitation or aortic stenosis (n¼ 42); a nondilated left
ventricle, defined as a LV end-diastolic dimension <32 mm/m height
(n ¼ 49)13; prior valve surgery (n ¼ 69); glomerular filtration rate<30
mL/min (n ¼ 4); or a life expectancy<1 year in the absence of AR
(n ¼ 3) were secondarily excluded. Patients undergoing a Ross procedure
were excluded as well (n¼ 31). Patients who had coronary artery disease or
had previously undergone coronary artery bypass graft surgery were not
excluded.
Group Selection
To reduce the effect of treatment selection bias, a propensity score anal-
ysis was performed.14,15 The propensity score was estimated by use of a
multiple logistic regression model where treatment was the dependent
variable, and plausible correlates of either the therapeutic decision or
survival acted as independent variables. The 5 covariables used to build
the propensity score were age, New York Heart Association (NYHA)
functional class I-II, presence of bicuspid AV, ejection fraction, and the
mechanism of AR. The calculated propensity scores were then used to
select pairs of patients with matched propensity scores in the 2 treatment
groups (1:1 match) within a caliper of 0.15 standard deviations of the
propensity score, using STATA 10.0 software (Stata Corporation, College
Station, Tex) and the psmatch routine. The propensity score yielded 44
matched pairs of patients.
Information on postoperative events and functional class was obtained
for all patients between January and April 2013. Cardiac events and causes
of death were ascertained by contacting the patients’ physicians, the
patients themselves if alive or their family, and by reviewing death certif-
icates. Follow-up was 97% complete.
Echocardiography
Preoperative and follow-up echocardiographic examinations were
performed using commercially available ultrasound systems. All patients
underwent a comprehensive examination, including M-mode and
2-dimensional echocardiography, as well as conventional and color
Doppler examinations. All tests were conducted by experienced
echocardiographers.
The severity of AR was assessed semiquantitatively on a scale of 1þ to
4þ by an integrated approach that included the size of the regurgitant jet in
the left ventricular cavity; the proximal regurgitant jet width; the jet decel-
eration rate; the magnitude of the diastolic flow reversal in descending
aorta; the size of the proximal convergence zone; and, when available,
the regurgitant volume and the effective regurgitant orifice area. Severe
AR was defined as grade 3þ AR or greater. The approach to semiquantifi-
cation used in our study is in agreement with prevailing guidelines at the
time of examination.16
Surgical Procedures
The choice of surgical technique was left at the discretion of the
attending surgeon who took into account the referring physicians’ and1914 The Journal of Thoracic and Cardiovascular Surthe patients’ preferences. The choice between an attempt to valve repair,
without any guarantee in terms of long-term results, and AVR was clearly
presented to every patient and referring physician. Although themajority of
patients accepted the risk and underwent AV repair, a few patients refused
and preferred to undergo AVR.
Surgical repair of the AV involved a variety of techniques tailored to
each individual dysfunction identified. These techniques have been exten-
sively described elsewhere.10 The prostheses used in AVRweremechanical
in 15 patients and biological in 29 patients. The choice of prosthesis was
discussed in detail among the informed patient, his or her cardiologist,
and the surgeon, in accordance with prevailing guidelines. In general, bio-
prosthetic AVR was proposed to patients aged 65 years or older, whereas
mechanical AVR was preferred in patients younger than age 60 years.
Between the ages of 60 and 65 years, both substitutes were usually pro-
posed and the final choice took into account possible contraindications
and patients’ preferences.
Statistical Analysis
All statistical analyses were performed using SPSS version 20.0 soft-
ware (IBM-SPSS Inc, Armonk, NY). Continuous variables were expressed
as mean  1 standard deviation, with categorical variables as counts and
percentages. To compare groups, student paired t test or McNemar c2 tests
were used when appropriate.
A Cox proportional-hazards survival model for matched data was built
for determination of the factors independently associated with outcome.
For the univariate analysis, all clinical, angiographic, and echocardio-
graphic variables were proposed for inclusion. Variables with P< .10
were subsequently submitted to a multivariate Cox proportional-hazards
survival model. For this purpose, a preliminarymodel was built fromwhich
the choice of treatment was excluded. The ability of the choice of treatment
to improve the prediction of death by this preliminary model was then
tested.
Cardiovascular events and reoperation-free survivals in the 2 treatment
groups were computed using the Kaplan-Meier method and compared us-
ing the log-rank c2 test. For each patient included in the study, the corre-
sponding average age- and gender-specific annual mortality rates of the
Belgian general population were obtained and an expected survival curve
was constructed.
The authors had full access to and take full responsibility for the integ-
rity of the data. All authors read and agreed to the article as written.
RESULTS
The strategy of the analysis was to compare the matched
AV repair group with the AVR group regarding baseline
characteristics of the patients; overall survival; operative-
free survival; and survival free of cardiac events, including
reoperations, recurrent AR, and NYHA functional class at
last follow-up.
Baseline Characteristics
Table 1 shows the baseline demographic and clinical
characteristics of the study population. Baseline hemody-
namic and echocardiographic characteristics are shown in
Table 2. Operative data are shown in Tables 3 and 4.
Indications for surgery were presence of symptoms
(n ¼ 32, 8 for NYHA functional class II symptoms and
24 NYHA class III-IV symptoms), asymptomatic dilation
of the ascending aorta (n ¼ 15), asymptomatic left ventric-
ular dysfunction (n ¼ 6), and asymptomatic left ventricular
dilation (n ¼ 35).gery c November 2014
FIGURE 1. Flow chart of the study population. AV, Aortic valve; AR, aortic regurgitation; CABG, coronary artery bypass graft; MR, mitral regurgitation;
TR, tricuspid regurgitation; AS, aortic stenosis; LV, left ventricle; LVEDD, left ventricular end diastolic diameter;GFR, glomerular filtration rate; AVR, aortic
valve replacement.
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During a mean follow-up of 6.8  4.7 years, 23 patients
died, 7 in AV repair group (2 heart failure, 1 postoperative,
and 4 noncardiovascular deaths) and 16 in the AVR group
(4 heart failure, 4 sudden deaths, 2 postoperative, 1 stroke,
2 miscellaneous, and 3 noncardiovascular deaths). As
shown in Figure 2, 9-year overall survival was significantly
better after AV repair than after AVR (87%  6% vs
60%  9%; P ¼ .007). At 9 years, the cardiovascular sur-
vival was also superior to that after AVR (91%  5% vs
66%  9%; log rank P ¼ .009).
For the multivariate Cox proportional hazards analysis,
we first built a preliminary survival model where all the
demographic and clinical variables except treatment choice
were proposed for inclusion. This preliminary model
identified age (P< .001) and NYHA functional class I-II
(P ¼ .047) as factors independently associated with
outcome. The ability of the choice of treatment to improve
the prediction of death by this preliminary model was then
tested. As indicated in Table 5, the choice of treatmentThe Journal of Thoracic and Caradded significant prognostic information to that
provided by the 2 covariates initially retained in the model.
All 3 covariates independently contributed to long-term
survival with a significant benefit for AV repair (hazard
ratio [HR], 0.11; 95% confidence interval, 0.03-0.40;
P ¼ .001).
The propensity score was also entered together with the
treatment choice into a bivariate Cox proportional hazards
regression model to estimate the 9-year propensity score-
adjusted HR associated with the choice of treatment. In
this analysis as well, AV repair was found to provide a
significant survival advantage over AVR (HR, 0.10; 95%
confidence interval, 0.03-0.36; P ¼ .001).
Operative Mortality
Operative death was defined as a death occurring within
1 month of surgery or during the same hospitalization.
Operative death occurred in 1 of 44 patients in the AV repair
group (2%) compared with 2 of 44 patients in the AVR
group (5%) (P ¼ .56).diovascular Surgery c Volume 148, Number 5 1915
TABLE 1. Baseline demographic and clinical characteristics
Characteristic
Aortic valve repair (n ¼ 44) Aortic valve replacement (n ¼ 44)
P valuen or mean ± SD Range or% n Range or%
Age (mean y  SD) 65  10 40-81 63  12 36-82 .45
Male gender 32 72.7 36 81.8 .45
Smoking habits 13 29.5 17 38.6 .48
Hypertension 25 56.8 24 54.5 >.99
Diabetes mellitus 4 9.1 5 11.4 >.99
Hypercholesterolemia 18 40.9 13 29.5 .38
Prior PCI or CABG 1 2.3 0 0.0 —
Prior AMI 1 2.3 2 4.5 >.99
Prior stroke 2 4.5 2 4.5 >.99
PVD 2 4.5 2 4.5 >.99
COPD 7 15.9 4 9.1 .55
Preoperative atrial fibrillation 4 9.1 6 13.6 .75
GFR (mean mL/min  SD) 79  27 31-165 80  35 31-149 .82
NYHA functional class I-II 32 72.7 32 72.7 >.99
SD, Standard deviation; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; AMI, acute myocardial infarction; PVD, peripheral vascular disease;
COPD, chronic obstructive pulmonary disease; GFR, glomerular filtration rate; NYHA, New York Heart Association.
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During follow-up, 29 patients experienced 1 or more
cardiovascular events, 11 in the AV repair group (3 car-
diovascular deaths, 3 reoperations, 1 stroke, 1 transplanta-
tion, 1 septicemia, and 2 other vascular events), and 18 in
the AVR group (13 cardiovascular deaths, 1 reoperation
on the aortic valve, 1 major bleed, 1 transplantation, 1
heart failure, and 1 percutaneous coronary intervention).
As shown in Figure 3, cardiovascular event-free
survival tended to be better in the AV repair group than
in the AVR group (68%  8% vs 45%  11%;
P ¼ .30).
During follow-up, 4 patients needed an aortic valve
reoperation; 3 in the AV repair group for recurrent
severe AR and 1 in the AVR group for endocarditis.
In the AV repair group, the mechanisms of recurrent
AR were rupture of the right coronary sinus into the
right atrium in 1 patient, scarring and calcification in
another patient, and residual prolapse in the remaining
patient. As shown in Figure 4, 9-year reoperation-free
survival tended to be lower in the AV repair groupTABLE 2. Baseline hemodynamic and echocardiographic data
Characteristic
Aortic valve repair (n ¼ 44)
n or mean ± SD Range or
Heart rate (bpm) 71  15 41-10
Systolic blood pressure (mm Hg) 142  22 100-19
Diastolic blood pressure (mm Hg) 60  14 30-85
LV end-diastolic dimensions (mm) 64  8 52-91
LV end-systolic dimensions (mm) 45  9 29-73
LV ejection fraction (%) 52  13 25-84
CAD 13 29.5
Euroscore (%) 7  7 2-33
SD, Standard deviation; LV, left ventricular; CAD, coronary artery disease.
1916 The Journal of Thoracic and Cardiovascular Surthan in the AVR group (92%  4% vs 98%  2%;
P ¼ .35).
Echocardiographic Follow-up
Complete echocardiographic follow-up data could be
obtained in all but 19 patients (14 deaths, 3 lost for
follow-up, and 2 living abroad). At the latest echocardio-
graphic visit, none of the 28 AVR patients displayed
more than trace (n ¼ 11) or 1þ residual (n ¼ 17) AR. By
contrast, among the 41 AV repair patients 6 (15%)
exhibited no or trivial AR, 21 (51%) had 1þ
residual AR, 11 (27%) had 2þ residual AR, and 3 (7%)
had 3þ residual AR. As mentioned earlier, all 3 patients
with 3þ residual AR subsequently underwent reoperation.
Freedom from aortic insufficiency greater than grade 2þ in
AV repair was 68% at 9 years.
NYHA Functional Class
At long-term follow-up, NYHA functional class was
similar in the AV repair and AVR groups (1.3  0.6 vs
1.2  0.5; P ¼ .18).Aortic valve replacement (n ¼ 44)
P value% n or mean ± SD Range or%
7 70  14 42-100 .67
0 143  27 90-190 .82
56  14 30-90 .11
66  8 50-87 .11
47  9 32-66 .27
52  13 19-72 .90
11 25.0 .80
6  8 2-38 .99
gery c November 2014
TABLE 3. Operative and postoperative data
Characteristic
Aortic valve repair (n ¼ 44) Aortic valve replacement (n ¼ 44)
P valuen or mean ± SD Range or% n or mean ± SD Range or%
Crossclamp time (min) 86  33 32-167 94  36 25-205 .22
ECC time (min) 111  42 42-222 122  49 40-254 .21
Associated procedures
CABG 9 20.5 12 27.3 .58
No. of arterial grafts per patient 0.83 0-1 0.75 0-1 —
Mitral valve repair 4 9.1 6 13.6 .73
Aortic root replacement 23 52.3 16 36.4 .12
Timing of surgery
Elective 43 97.7 43 97.7 >.99
Urgent 1 2.3 1 2.3 >.99
Emergent 0 0.0 0 0.0 —
Aortic valve anatomy
Tricuspid 39 88.6 36 81.8 .55
Bicuspid 5 11.4 8 18.2 .55
Mechanism of atrial repair
Type 1 dysfunction 12 27.3 16 36.4 .52
Type 2 dysfunction 14 31.8 10 22.7 .45
Type 3 dysfunction 18 40.9 18 40.9 >.99
SD, Standard deviation; ECC, extracorporeal circulation time; CABG, coronary arterial bypass graft.
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In patients with severe mitral regurgitation, mitral valve
repair has been shown to provide both a low operative
risk and an excellent late survival, with a low incidence of
valve-related complications. These results are at variance
with those obtained with mitral valve replacement.17
Accordingly, mitral valve repair, if feasible, has become
the preferred option for treating patients with severe mitral
regurgitation.1,2 Since the early days of cardiac surgery, AV
repair has also been attempted for treating patients with
severe AR, but the results have been quite varied. Thanks
to innovations in operative techniques9 and a better under-
standing of the functional anatomy of the aortic valve and
root,10 the immediate results of AV reconstructive surgery
have dramatically improved. Although the durability ofTABLE 4. Surgical repair techniques used in the different aortic valve
dysfunctional subsets
Correction performed
Type 1
(n ¼ 12)
Type 2
(n ¼ 14)
Type 3
(n ¼ 18)
Root procedures
Root reimplantation 10 4 8
Root remodeling 1 1 1
Supracoronary replacement 0 0 1
Cuspal procedures
Free edge plication 3 7 7
Resection 0 2 6
Shaving/decalcification 1 1 2
Free edge reinforcement 0 8 6
Patch extension 0 0 2
Subcommisural annuloplasty 3 9 7
The Journal of Thoracic and Carthis approach has also been documented, its superiority to
prosthetic valve replacement has not yet been established.
Our consecutive series is the first to directly compare AV
repair and AVR for the treatment of severe AR. We found
that patients undergoing surgical correction of severe AR
incur a low operative mortality, both after AV repair and
AVR; patients undergoing AV repair have a significantly
better long-term overall and cardiovascular survival thanFIGURE 2. Kaplan-Meier survival curves comparing overall postopera-
tive survival among patients undergoing aortic valve (AV) repair (solid
line) or aortic valve replacement (AVR) (dashed line). Numbers at bottom
indicate patients at risk. The dotted line shows the survival of the age-
and gender-matched Belgian population.
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TABLE 5. Additional prognostic value of aortic regurgitation repair
by use of Cox proportional hazards analysis
Covariate
Initial model
c2 to
enter P value
Hazard ratio
(95% CI)
c2 to
remove P value
Age (per y) 1.17 (1.08-1.26) 23.1 <.001
NYHA functional
class I-II
0.38 (0.15-0.99) 3.7 .047
Aortic valve repair 14.0 <.001
CI, Confidence interval; NYHA, New York Heart Association.
FIGURE 4. Kaplan-Meier survival curve comparing freedom from aortic
valve reoperations among patients undergoing aortic valve (AV) repair
(solid line) or aortic valve replacement (AVR) (dashed line).
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fewer cardiovascular events); and AV repair results in a
slightly increased, albeit not statistically significant, long-
term risk of reoperation compared with AVR.
AV Repair for the Treatment of AR
Although AVR remains the gold standard for the surgical
correction of AR, the clinical applicability of AV repair has
recently gained momentum. The clinical imperatives
driving the push for AV repair are primarily to avoid
the risk of prosthetic valve complications such as thrombo-
embolism, endocarditis, bleeding, and structural valve
deterioration, which altogether occur at a pace of 2% to
7% per year.4,5
Although techniques of AV repair have been documented
for more than 40 years, their use has remained anecdotal
until the development and dissemination of valve-sparing
aortic root replacement procedures during the early
1990s.18,19 Initially designed for the treatment of type 1
AV dysfunction; that is, aortic root dilation, theseFIGURE 3. Kaplan-Meier survival curves comparing postoperative car-
diovascular event-free survival among patients undergoing aortic valve
(AV) repair (solid line) or aortic valve replacement (AVR) (dashed line).
CV, Cardiovascular.
1918 The Journal of Thoracic and Cardiovascular Surprocedures require a clear understanding of the functional
anatomy of the AV and root to be successful. The early
experience with these procedures was indeed quite
disappointing, with as many as 30% of patients presenting
with recurrent severe AR and eventually needing a
reoperation.20,21 It soon became apparent that the primary
cause of recurrent AR was the presence of a cuspal
prolapse, which either was preexisting but went
unrecognized, or was induced by the reduction of the
sinotubular junction intraoperatively.22 These unsatisfac-
tory results fostered the development of a variety of cuspal
repair techniques aimed at correcting preexisting or surgi-
cally induced cusp prolapses. The systematic application
of these techniques in the presence of any residual prolapse
has markedly improved the outcome of valve-sparing aortic
root replacement procedures23,24 and has laid the foundation
for their use in patients with severe AR due to isolated type 2
AV dysfunction; that is, those with primary cuspal prolapses
but without significant aortic root pathology.25,26 With
increasing experience, the indication was even extended to
patients with bicuspid aortic valve disease and those
with type 3 AV dysfunction,27-29 such as degenerative
calcified AR, rheumatic AR, or AV endocarditis. Results
for these newer indications have not been as robust as
those reported in patients with type 1 and/or type 2
dysfunction, owing probably to the large amount of
diseased tissue that has to be excised and to the use of
biological patches to close the resulting defects.10,28 In
bicuspid aortic valves, results have also been less long-
lasting when trying to respect an initially asymmetrical
valve geometry28 or when reducing the size of the aorto-
ventricular junction by use of subcommissural annuloplasty
stiches.29gery c November 2014
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of experience with the use of AV repair surgery for the treat-
ment of severe AR. It thus includes our initial learning curve
as well as the many refinements in operative techniques that
were introduced during the study period. Despite this, our
data indicate that AV repair is associated with low operative
mortality (around 1%), good medium-term survival (87%
at 9 years), an acceptable risk of reoperation (8% at 9
years), and a relatively low cardiovascular event rate
(32% at 9 years). These results compare favorably with
those reported by other investigators. In 274 patients under-
going AV repair for type 1 AV dysfunction, including 46 pa-
tients undergoing operation for acute type A dissection,
Aicher and colleagues23 reported an operative mortality of
3.6%, a 5-year overall survival of 91%, and a 4% risk of
reoperation at 5 years. The same authors subsequently re-
ported their experience in 316 patients undergoing bicuspid
AV repair, in whom operative mortality was only 0.6%,
5-year survival was 99%, and the risk of reoperation at 5
years was 12%.28 Similarly good results were reported by
Minakata and colleagues,7 in the meta-analysis of Carr
and Savage,6 and more recently by Svensson and
colleagues30 and Sharma and colleagues.31 Altogether, the
available data suggest that AV repair is a safe procedure,
with good medium- to long-term results with respect to
overall survival and risk of reoperation.
Comparison With AVR
Very few studies have compared the outcome of patients
after AV repair or AVR and none have directly compared
these 2 techniques. In their meta-analysis, Carr and Savage6
compared the results of AV repair with those of AVR using
selected data from the literature. Their comparison
suggested that the 2 approaches expose patients to a similar
5-year risk of reoperation, and that AV repair might be asso-
ciated with better medium-term survival than bioprosthetic
AVR. Although their results are quite similar to those
reported in our study, their analysis was flawed by the large
age difference between the patients undergoing AV repair
and those undergoing AVR. More recently, Svensson and
colleagues30 made a similar comparison between AV repair
and bioprosthetic AVR, using premarket approval data for
the Carpentier Edwards (Irvine, Calif) bovine pericardial
aortic valve prosthesis. Although their data also suggested
that AV repair results in a better long-term survival, their
analysis was limited by the large age difference between
members of the AV repair and AVR groups and by the
fact that most patients who underwent AVR were operated
on for severe aortic stenosis or combined stenosis and
regurgitation (80%), whereas a minority had isolated
AR (17%).
Our study is thus the first to provide a direct comparison
between AV repair and AVR in patients with severe AR. To
overcome the absence of randomization and compensate forThe Journal of Thoracic and Carthe differences in baseline characteristics between our 2
treatment groups, we performed a propensity score analysis.
The results of this analysis showed a large survival
advantage in favor of patients undergoing AV repair
compared with those undergoing AVR. Furthermore, our
data also suggest a trend toward lower operative mortality
with AV repair. Importantly, we also found that the
improved outcome after AV repair was not obtained at
the expense of a significant increase in valve-related
complications. In particular, the rate of thromboembolism,
severe bleeding, and endocarditis as well as the incidence
of reoperation were quite small and did not significantly
differ between AV repair and AVR.
Limitations
There are several limitations to our study that should be
acknowledged. First, despite the completeness of our
follow-up data and the prospective nature of the database
from which the data were retrieved, our study has a retro-
spective design, patients were not randomized between
AV repair and AVR, and the number of patients undergoing
AVR in our series was relatively small. Although we used a
propensity score analysis to compare long-term survival
among matched pairs of patients, we cannot exclude the
possibility that unaccounted for confounding factors
contributed to our results. There is no doubt that a
prospective randomized trial would provide a definite
demonstration of the superiority of aortic reconstruction.
Second, AV repair is a demanding procedure that is
currently performed only in few high volume and highly
specialized centers. Because this technique requires special
skills and experience, one must be careful when translating
our results to smaller or less experienced centers that have
not had preliminary special training. Third, we used a
semiquantitative multiparametric approach to assess AR
severity. Although this integrated approach is recommen-
ded both by the American Society of Echocardiography13
and the European Association of Echocardiography,32 the
absence of quantitative measures of AR severity, such as
the regurgitant volume, the effective regurgitant orifice
area, or both, could be viewed as a possible limitation. To
address this issue, we analyzed separately the outcome of
patients operated on before and after we started to system-
atically acquire quantitative parameters of AR severity in
our echocardiographic laboratory; that is, in 2006. Although
the follow-up is shorter for the period 2006 to 2010, the
survival benefits conferred by AV repair were found to be
similar between the periods 1995 to 2005 and 2005 to
2010 (data not shown).
CONCLUSIONS
Our study shows that after adjustment for all
confounding variables using a multivariate analysis and a
propensity score matching procedure, AV repair is a strongdiovascular Surgery c Volume 148, Number 5 1919
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Dindependent predictor of improved survival, with excellent
freedom from reoperation, in comparison with AVR. These
data suggest that AV repair should be the preferred method
of correction of AR and should be considered in all cases in
which surgery is contemplated and the valve is considered
to be repairable.
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